U.S. flag

An official website of the United States government

NM_022072.5(NSUN3):c.454T>A (p.Cys152Ser) AND Combined oxidative phosphorylation deficiency 48

Germline classification:
Pathogenic (1 submission)
Last evaluated:
Sep 17, 2020
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of clinical impact:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Somatic classification
of oncogenicity:
None
Review status:
(0/4) 0 stars out of maximum of 4 stars
no assertion criteria provided
Record status:
current
Accession:
RCV001256013.1

Allele description [Variation Report for NM_022072.5(NSUN3):c.454T>A (p.Cys152Ser)]

NM_022072.5(NSUN3):c.454T>A (p.Cys152Ser)

Gene:
NSUN3:NOP2/Sun RNA methyltransferase 3 [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
3q11.2
Genomic location:
Preferred name:
NM_022072.5(NSUN3):c.454T>A (p.Cys152Ser)
HGVS:
  • NC_000003.12:g.94084438T>A
  • NM_022072.5:c.454T>AMANE SELECT
  • NP_071355.1:p.Cys152Ser
  • NC_000003.11:g.93803282T>A
Protein change:
C152S; CYS152SER
Links:
OMIM: 617491.0003; dbSNP: rs2077284206
NCBI 1000 Genomes Browser:
rs2077284206
Molecular consequence:
  • NM_022072.5:c.454T>A - missense variant - [Sequence Ontology: SO:0001583]

Condition(s)

Name:
Combined oxidative phosphorylation deficiency 48
Identifiers:
MONDO: MONDO:0033566; MedGen: C5436602; OMIM: 619012

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV001432790OMIM
no assertion criteria provided
Pathogenic
(Sep 17, 2020)
germlineliterature only

PubMed (1)
[See all records that cite this PMID]

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlinenot providednot providednot providednot providednot providednot providedliterature only

Citations

PubMed

Correction to: Novel Biallelic NSUN3 Variants Cause Early-Onset Mitochondrial Encephalomyopathy and Seizures.

Paramasivam A, Meena AK, Venkatapathi C, Pitceathly RDS, Thangaraj K.

J Mol Neurosci. 2020 Dec;70(12):1966. doi: 10.1007/s12031-020-01652-2.

PubMed [citation]
PMID:
32671698
PMCID:
PMC7658060

Details of each submission

From OMIM, SCV001432790.1

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedliterature only PubMed (1)

Description

In an 8-month-old boy, born of consanguineous East Asian parents, with combined oxidative phosphorylation deficiency-48 (COXPD48; 619012), Paramasivam et al. (2020) identified compound heterozygous missense mutations in exon 3 of the NSUN3 gene: a c.454T-A transversion, resulting in a cys152-to-ser (C152S) substitution, and a c.421G-C transversion, resulting in an ala141-to-pro (A141P; 617491.0004) substitution. The mutations, which were found by targeted sequencing and confirmed by Sanger sequencing, segregated with the disorder in the family. Both occurred at highly conserved residues in the protein and neither were present in several public databases, including gnomAD. Functional studies of the variant and studies of patient cells were not performed.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlinenot providednot providednot providednot providednot providednot providednot providednot provided

Last Updated: Apr 23, 2022